Prostaglandin modulation of airway inflammation and hyperresponsiveness in mice sensitized without adjuvant

Prostaglandins and Other Lipid Mediators

Volumn 92, Issue 1-4, 2010, Pages 44-53

  Swedin, Linda ^a   Ellis, Russ ^b   Neimert Andersson, Theresa ^a   Ryrfeldt, Åke ^a   Nilsson, Gunnar ^a   Inman, Mark ^b   Dahlén, Sven Erik ^a   Adner, Mikael ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

Airway hyperresponsiveness; Allergic mouse model; Cell infiltration; Chemokines; Cyclooxygenase inhibition; Cytokines; Eicosanoids

Indexed keywords

CYCLOOXYGENASE 1; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2; DICLOFENAC; FR 122047; INDOMETACIN; LUMIRACOXIB; PROSTAGLANDIN; PROSTAGLANDIN SYNTHASE; PROSTANOID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; EOSINOPHIL COUNT; FEMALE; GOBLET CELL; IC 50; INFLAMMATORY CELL; LUNG LAVAGE; MOUSE; MUSCLE MASS; NONHUMAN; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT HYPERRESPONSIVENESS; RESPIRATORY TRACT INFLAMMATION; SENSITIZATION;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BRONCHOALVEOLAR LAVAGE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE INHIBITORS; CYSTEINE; CYTOKINES; FEMALE; HYPERSENSITIVITY; IMMUNIZATION; INFLAMMATION; LEUKOTRIENES; LUNG; METHACHOLINE CHLORIDE; MICE; MICE, INBRED BALB C; OVALBUMIN; PROSTAGLANDINS; RESPIRATORY SYSTEM;

EID: 77952100026     PISSN: 10988823     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prostaglandins.2010.02.004     Document Type: Article

References (56)

1. 2 on allergen-induced airway responses and airway inflammation. Am J Respir Crit Care Med 159 1 (1999) 31-36
2. Pavord I.D., Wong C.S., Williams J., and Tattersfield A.E. Effect of inhaled prostaglandin E2 on allergen-induced asthma. Am Rev Respir Dis 148 1 (1993) 87-90
3. Peebles Jr. R.S., Hashimoto K., Morrow J.D., et al. Selective cyclooxygenase-1 and -2 inhibitors each increase allergic inflammation and airway hyperresponsiveness in mice. Am J Respir Crit Care Med 165 8 (2002) 1154-1160
4. Peebles Jr. R.S., Dworski R., Collins R.D., et al. Cyclooxygenase inhibition increases interleukin 5 and interleukin 13 production and airway hyperresponsiveness in allergic mice. Am J Respir Crit Care Med 162 2 Pt 1 (2000) 676-681
5. Carey M.A., Germolec D.R., Bradbury J.A., et al. Accentuated T helper type 2 airway response after allergen challenge in cyclooxygenase-1-/- but not cyclooxygenase-2-/- mice. Am J Respir Crit Care Med 167 11 (2003) 1509-1515
6. Gavett S.H., Madison S.L., Chulada P.C., et al. Allergic lung responses are increased in prostaglandin H synthase-deficient mice. J Clin Invest 104 6 (1999) 721-732
7. Swedin L., Neimert-Andersson T., Hjoberg J., et al. Dissociation of airway inflammation and hyperresponsiveness by cyclooxygenase inhibition in allergen challenged mice. Eur Respir J (2009)
8. Matsuoka T., Hirata M., Tanaka H., et al. Prostaglandin D2 as a mediator of allergic asthma. Science 287 5460 (2000) 2013-2017
9. Richter M., and Sirois P. Effects of eicosanoids, neuromediators and bioactive peptides on murine airways. Eur J Pharmacol 389 2-3 (2000) 225-234
10. Tilley S.L., Hartney J.M., Erikson C.J., et al. Receptors and pathways mediating the effects of prostaglandin E2 on airway tone. Am J Physiol Lung Cell Mol Physiol 284 4 (2003) L599-606
11. Williams C.M., and Galli S.J. Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice. J Exp Med 192 3 (2000) 455-462
12. Kobayashi T., Miura T., Haba T., et al. An essential role of mast cells in the development of airway hyperresponsiveness in a murine asthma model. J Immunol 164 7 (2000) 3855-3861
13. Chang Y.S., Kim Y.K., Bahn J.W., et al. Comparison of asthma phenotypes using different sensitizing protocols in mice. Korean J Intern Med 20 2 (2005) 152-158
14. Zhang Y., Lamm W.J., Albert R.K., Chi E.Y., Henderson Jr. W.R., and Lewis D.B. Influence of the route of allergen administration and genetic background on the murine allergic pulmonary response. Am J Respir Crit Care Med 155 2 (1997) 661-669
15. Conrad M.L., Yildirim A.O., Sonar S.S., et al. Comparison of adjuvant and adjuvant-free murine experimental asthma models. Clin Exp Allergy 39 8 (2009) 1246-1254
16. Wilson C.G., Akhter S., Mayer C.A., et al. Allergic lung inflammation affects central noradrenergic control of cholinergic outflow to the airways in ferrets. J Appl Physiol 103 6 (2007) 2095-2104
17. Zosky G.R., von Garnier C., Stumbles P.A., Holt P.G., Sly P.D., and Turner D.J. The pattern of methacholine responsiveness in mice is dependent on antigen challenge dose. Respir Res 5 (2004) 15
18. Seitzer U., Bussler H., Kullmann B., Petersen A., Becker W.M., and Ahmed J. Mouse strain specificity of the IgE response to the major allergens of Phleum pratense. Int Arch Allergy Immunol 136 4 (2005) 347-355
19. Bradding P., Walls A.F., and Holgate S.T. The role of the mast cell in the pathophysiology of asthma. J Allergy Clin Immunol 117 6 (2006) 1277-1284
20. Mitchell J.A., Akarasereenont P., Thiemermann C., Flower R.J., and Vane J.R. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 90 24 (1993) 11693-11697
21. Esser R., Berry C., Du Z., et al. Preclinical pharmacology of lumiracoxib: a novel selective inhibitor of cyclooxygenase-2. Br J Pharmacol 144 4 (2005) 538-550
22. Ochi T., Motoyama Y., and Goto T. The analgesic effect profile of FR122047, a selective cyclooxygenase-1 inhibitor, in chemical nociceptive models. Eur J Pharmacol 391 1-2 (2000) 49-54
23. Barnas G.M., Ho G., Green M.D., et al. Effects of analysis method and forcing waveform on measurement of respiratory mechanics. Respir Physiol 89 3 (1992) 273-285
24. Tomioka S., Bates J.H., and Irvin C.G. Airway and tissue mechanics in a murine model of asthma: alveolar capsule vs. forced oscillations. J Appl Physiol 93 1 (2002) 263-270
25. Hjoberg J., Shore S., Kobzik L., et al. Expression of nitric oxide synthase-2 in the lungs decreases airway resistance and responsiveness. J Appl Physiol 97 1 (2004) 249-259
26. Ellis R., Leigh R., Southam D., O'Byrne P.M., and Inman M.D. Morphometric analysis of mouse airways after chronic allergen challenge. Lab Invest 83 9 (2003) 1285-1291
27. Leigh R., Ellis R., Wattie J., et al. Dysfunction and remodeling of the mouse airway persist after resolution of acute allergen-induced airway inflammation. Am J Respir Cell Mol Biol 27 5 (2002) 526-535
28. Leigh R., Ellis R., Wattie J.N., et al. Type 2 cytokines in the pathogenesis of sustained airway dysfunction and airway remodeling in mice. Am J Respir Crit Care Med 169 7 (2004) 860-867
29. Leigh R., Southam D.S., Ellis R., et al. T-cell-mediated inflammation does not contribute to the maintenance of airway dysfunction in mice. J Appl Physiol 97 6 (2004) 2258-2265
30. Southam D.S., Ellis R., Wattie J., and Inman M.D. Components of airway hyperresponsiveness and their associations with inflammation and remodeling in mice. J Allergy Clin Immunol 119 4 (2007) 848-854
31. Inman M.D., Ellis R., Wattie J., Denburg J.A., and O'Byrne P.M. Allergen-induced increase in airway responsiveness, airway eosinophilia, and bone-marrow eosinophil progenitors in mice. Am J Respir Cell Mol Biol 21 4 (1999) 473-479
32. Neimert-Andersson T., Thunberg S., Swedin L., et al. Carbohydrate-based particles reduce allergic inflammation in a mouse model for cat allergy. Allergy 63 5 (2008) 518-526
33. Hata A.N., Lybrand T.P., and Breyer R.M. Identification of determinants of ligand binding affinity and selectivity in the prostaglandin D2 receptor CRTH2. J Biol Chem 280 37 (2005) 32442-32451
34. Hata A.N., Zent R., Breyer M.D., and Breyer R.M. Expression and molecular pharmacology of the mouse CRTH2 receptor. J Pharmacol Exp Ther 306 2 (2003) 463-470
35. Harrington L.S., Lucas R., McMaster S.K., et al. COX-1, and not COX-2 activity, regulates airway function: relevance to aspirin-sensitive asthma. FASEB J 22 11 (2008) 4005-4010
36. Jaffar Z., Wan K.S., and Roberts K. A key role for prostaglandin I2 in limiting lung mucosal Th2, but not Th1, responses to inhaled allergen. J Immunol 169 10 (2002) 5997-6004
37. Idzko M., Hammad H., van Nimwegen M., et al. Inhaled iloprost suppresses the cardinal features of asthma via inhibition of airway dendritic cell function. J Clin Invest 117 2 (2007) 464-472
38. Nagao K., Tanaka H., Komai M., Masuda T., Narumiya S., and Nagai H. Role of prostaglandin I2 in airway remodeling induced by repeated allergen challenge in mice. Am J Respir Cell Mol Biol 29 3 Pt 1 (2003) 314-320
39. Takahashi Y., Tokuoka S., Masuda T., et al. Augmentation of allergic inflammation in prostanoid IP receptor deficient mice. Br J Pharmacol 137 3 (2002) 315-322
40. Schulman E.S., Newball H.H., Demers L.M., Fitzpatrick F.A., and Adkinson Jr. N.F. Anaphylactic release of thromboxane A2, prostaglandin D2, and prostacyclin from human lung parenchyma. Am Rev Respir Dis 124 4 (1981) 402-406
41. Dahlen S.E., Hansson G., Hedqvist P., Bjorck T., Granstrom E., and Dahlen B. Allergen challenge of lung tissue from asthmatics elicits bronchial contraction that correlates with the release of leukotrienes C4, D4, and E4. Proc Natl Acad Sci USA 80 6 (1983) 1712-1716
42. Irvin C.G., and Bates J.H. Measuring the lung function in the mouse: the challenge of size. Respir Res 4 (2003) 4
43. Ito M., and Matsuoka I. Regulation of purinergic signaling by prostaglandin E2 in murine macrophages. J Pharmacol Sci 107 4 (2008) 443-450
44. Minami M., Shimizu K., Okamoto Y., et al. Prostaglandin E receptor type 4-associated protein interacts directly with NF-kappaB1 and attenuates macrophage activation. J Biol Chem 283 15 (2008) 9692-9703
45. Takayama K., Garcia-Cardena G., Sukhova G.K., Comander J., Gimbrone Jr. M.A., and Libby P. Prostaglandin E2 suppresses chemokine production in human macrophages through the EP4 receptor. J Biol Chem 277 46 (2002) 44147-44154
46. Hashimoto K., Sheller J.R., Morrow J.D., et al. Cyclooxygenase inhibition augments allergic inflammation through CD4-dependent, STAT6-independent mechanisms. J Immunol 174 1 (2005) 525-532
47. Zhou W., Newcomb D.C., Moore M.L., Goleniewska K., O'Neal J.F., and Peebles Jr. R.S. Cyclooxygenase inhibition during allergic sensitization increases STAT6-independent primary and memory Th2 responses. J Immunol 181 8 (2008) 5360-5367
48. Buc M., Dzurilla M., Vrlik M., and Bucova M. Immunopathogenesis of bronchial asthma. Arch Immunol Ther Exp (Warsz) 57 5 (2009) 331-344
49. Rothenberg M.E., and Hogan S.P. The eosinophil. Annu Rev Immunol 24 (2006) 147-174
50. Maurer M., and von Stebut E. Macrophage inflammatory protein-1. Int J Biochem Cell Biol 36 10 (2004) 1882-1886
51. Erjefalt J.S., Uller L., Malm-Erjefalt M., and Persson C.G. Rapid and efficient clearance of airway tissue granulocytes through transepithelial migration. Thorax 59 2 (2004) 136-143
52. Uller L., Lloyd C.M., Rydell-Tormanen K., Persson C.G., and Erjefalt J.S. Effects of steroid treatment on lung CC chemokines, apoptosis and transepithelial cell clearance during development and resolution of allergic airway inflammation. Clin Exp Allergy 36 1 (2006) 111-121
53. Fireman P. Understanding asthma pathophysiology. Allergy Asthma Proc 24 2 (2003) 79-83
54. Bousquet J., Jeffery P.K., Busse W.W., Johnson M., and Vignola A.M. Asthma from bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med 161 5 (2000) 1720-1745
55. Brightling C.E., Bradding P., Symon F.A., Holgate S.T., Wardlaw A.J., and Pavord I.D. Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med 346 22 (2002) 1699-1705
56. Martin T.R., Takeishi T., Katz H.R., Austen K.F., Drazen J.M., and Galli S.J. Mast cell activation enhances airway responsiveness to methacholine in the mouse. J Clin Invest 91 3 (1993) 1176-1182